Regional News Archives - Page 67 of 190 - Journal for Clinical Studies

Current Edition

Regional News

As rivals eye ‘unjustified royalties,’ Pfizer partner sues to defend COVID-19 shot Comirnaty

Pfizer has already reeled in tens of billions of dollars in sales for its COVID-19 shot Comirnaty. Now, one of the New York pharma's partners says rival companies are...

23 March 2022 Regional News Comirnaty | COVID-19

Continue Reading →

Regional News

Biotech execs who pinched Genentech trade secrets headed to prison

Top execs at Taiwanese biosimilars outfit JHL Biotech are headed to prison after pleading guilty last August to stealing trade secrets from Roche’s Genentech. Rac...

17 March 2022 Regional News biosimilars | biotech

Continue Reading →

Regional News

Biogen piles on more long-term Aduhelm data, linking biomarker to Alzheimer’s clinical benefit

Despite a disastrous commercial rollout, Biogen is still producing longer-term data for beleaguered Alzheimer’s disease therapy Aduhelm. In patients who’ve been t...

17 March 2022 Regional News Aduhelm | Alzheimer

Continue Reading →

Regional News

Lilly and Boehringer’s Jardiance, trailing AZ’s Farxiga in chronic kidney disease, posts efficacy win

After a series of wins in heart failure, Eli Lilly and Boehringer Ingelheim are pumping the breaks on a late-stage Jardiance trial in chronic kidney disease (CKD) tha...

17 March 2022 Regional News Boehringer | chronic

Continue Reading →

Regional News

AbbVie, Eli Lilly, Novartis and more cut back in Russia amid corporate exodus over Ukraine war

Since the invasion of Ukraine, hundreds of companies have announced a pause or withdrawal of businesses in Russia. Drugmakers Eli Lilly, Novartis and AbbVie are among...

17 March 2022 Regional News AbbVie | Eli Lilly

Continue Reading →

Regional News

Sprout hopes women will think pink when it comes to treating Hypoactive Sexual Desire Disorder

Pfizer’s Viagra is so much a part of the cultural landscape that, “little blue pill” is often all that’s needed to identify the drug. Not so much for Addyi, Sprout Ph...

17 March 2022 Regional News Desire | disorder

Continue Reading →

Regional News

BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report

Homegrown mRNA players BioNTech and CureVac have signed on to supply Germany with vaccines against future health emergencies for years to come. Germany will pay u...

17 March 2022 Regional News BioNTech | CureVac

Continue Reading →

Regional News

Take Part in the Pharmapack Survey

Pharmapack Europe is inviting its community to take part in an in-depth market insights survey exploring the drug delivery and pharma packaging industry and future tr...

17 March 2022 Regional News 2022 | pharma

Continue Reading →

Regional News

That key Gilead breast cancer readout? Try 2024, and don’t get your hopes up: analyst

Gilead Sciences just tipped off what sounded like mixed results for Trodelvy, the cornerstone of the Big Biotech’s oncology ambitions. Now, one analyst suggests inves...

9 March 2022 Regional News bladder | breast

Continue Reading →

Regional News

Gilead drops unclear win for key Trodelvy breast cancer trial, poking holes in CEO’s oncology plan

Gilead Sciences has a lot of its oncology ambitions riding on Trodelvy’s success beyond its existing approvals. While investors have been waiting with bated breath fo...

9 March 2022 Regional News breast | cancer

Continue Reading →